MétaCan
Menu
Back to cohort
Record W4290987241 · doi:10.1093/ndt/gfac238

Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis

2022· article· en· W4290987241 on OpenAlexafffundabout
Arenn Jauhal, Heather N. Reich, Michelle Hladunewich, Moumita Barua, Bettina E. Hansen, David Naimark, Stéphan Troyanov, Daniel C. Cattran, Neil Ryan, Rex Pui Kin Lam, Manuela Romano, Steven M. Albert, Ramona Aslahi, Prabhlin Aujla, Nancy Barrese, Murray Berall, A. Berbece, S. Bhandhal, D.R. Birbrager, Philip Boll, George P. Buldo, Carl J. Cardella, Charles K. Chan, Paul K.S. Chan, A. Charest, David Cherney, Mala Chidambaram, Sin‐Ming Chow, Edward Cole, Matthew J. Cummings, Susie Donnelly, Amy L. Dunn, A. El-Firjani, S Fenton E Fong, Jasmine L.F. Fung, Jonathan Goldstein, Ziv Harel, Gavril Hercz, Sarbjit V. Jassal, Sahar Kajbaf, K.S. Kamel, Ailing Kang, S. Karanicolas, Vincent Ki, S.J. Kim, David H. Kim, Ana Konvalinka, Kiran Kaur Kundhal, Valérie S. Langlois, Poli Lekas, Ilan Lenga, Christoph Licht, Jennifer Lipscombe, Charmaine E. Lok, Jasen Ly, Motharasan Manogaran, Regina McQuillan, Philip A. McFarlane, Hemalkumar B. Mehta, David C. Mendelssohn, Jonathan Miller, Gordon Nagai, Bharat Nathoo, Gihad Nesrallah, Michael Pandes, S.B. Pandeya, Rulan S. Parekh, Rachel Pearl, York Pei, David Perkins, Jeffrey Perl, Andreas Pierratos, R Prasad, S Radhakrishnan, Maya K. Rao, R Richardson, Julia Roscoe, Amani Roushdi, Jaineet Sachdeva, D. G. Sapir, Joanna Sasal, Jeffrey Schiff, J. W. Scholey, Martin A. Schreiber, Xiuhong Shan, Nazema Y. Siddiqui, Tabo Sikaneta, C.V. Silva Gomez, Sandeep Singh, Ravish Singhal, Alex Hardip Sohal, Andrew J. Steele, Sunita Suneja, Esther Szaky, Derrick Y. Tam, Paul Tam, L Teskey, Kathryn Tinckam, R. Ting, Stephen Kwok‐Wing Tsui, Paul Turner, Davinder Wadehra, Jose Arturo Wadgymar, Rachel M. Wald, Aziz Walele, Lindsay L. Warner, Cheng‐Yu Wei, Jordan Weinstein, Catharine Whiteside, S. Wijeyasekaran, Grace Lai‐Hung Wong, George Wu, Teraiza Yassa, Darren A. Yuen, Jeffrey S. Zaltzman

Bibliographic record

VenueNephrology Dialysis Transplantation · 2022
Typearticle
Languageen
FieldMedicine
TopicRenal Diseases and Glomerulopathies
Canadian institutionsUniversité de MontréalHôpital du Sacré-Cœur de MontréalSunnybrook Health Science CentreUniversity of TorontoUniversity Health Network
FundersToronto East General Hospital Foundation
KeywordsMedicineFocal segmental glomerulosclerosisRenal functionProteinuriaNephrotic syndromeInternal medicineKidney diseaseRetrospective cohort studyConfidence intervalCohortPediatricsKidney

Abstract

fetched live from OpenAlex

BACKGROUND: Although the clinical benefit of obtaining a remission in proteinuria in nephrotic patients with focal segmental glomerulosclerosis (FSGS) is recognized, the long-term value of maintaining it and the impact of relapses on outcome are not well described. METHODS: We examined the impact of remissions and relapses on either a 50% decline in kidney function or end-stage kidney disease (combined event) using time-dependent and landmark analyses in a retrospective study of all patients from the Toronto Glomerulonephritis Registry with biopsy-proven FSGS, established nephrotic-range proteinuria and at least one remission. RESULTS: In the 203 FSGS individuals with a remission, 89 never relapsed and 114 experienced at least one relapse. The first recurrence was often followed by a repeating pattern of remission and relapse. The 10-year survival from a combined event was 15% higher in those with no relapse versus those with any relapse. This smaller than anticipated difference was related to the favourable outcome in individuals whose relapses quickly remitted. Relapsers who ultimately ended in remission (n = 46) versus in relapse (n = 68) experienced a 91% and 32% 7-year event survival (P < .001), respectively. Using time-varying survival analyses that considered all periods of remission and relapse in every patient and adjusting for each period's initial estimated glomerular filtration rate, the state of relapse was associated with a 2.17 (95% confidence interval 1.32-3.58; P = .002) greater risk of experiencing a combined event even in this FSGS remission cohort. CONCLUSION: In FSGS, unless remissions are maintained and relapses avoided, long-term renal survival remains poor. Treatment strategies addressing remission duration remain poorly defined and should be an essential question in future trials.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.015
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.034

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.015
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.266
Teacher spread0.244 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2022
Admission routes3
Has abstractyes

Explore more

Same venueNephrology Dialysis TransplantationSame topicRenal Diseases and GlomerulopathiesFrench-language works237,207